Since E-CRP-1 does not bind to PCh, and hence cannot activate the complement system, these results indicated that the increased resistance to infection in E-CRP-1-treated mice was due to combined actions of E-CRP-1 and endogenous mouse WT CRP. Here, CRP is linked to infection.